RUNX1 and prostate carcinoma: For example, the ectopic expression of RUNX1 in esophageal adenocarcinoma cells reduced the anchorage-independent growth [19], and the knockdown of RUNX1 by siRNAs enhanced androgen-independent proliferation of prostate cancer cells [20].